Delinkage and the Patent System for Pharma: Trouble Ahead?
While the term “delinkage” has been around since at least 2005, it is not seen or heard very often. It is the term used in the biomedical field by lawyers and politicians to mean a new way of funding drug R&D such that the patent system could be replaced with the result that a drug monopoly would not exist and drug prices would be significantly lower. One of the advocates of this is Presidential candidate…